Intersect ENT, Inc. Net Change in Cash
Intersect ENT, Inc. reported Net Change in Cash of -$13.82 million for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-04.
Discontinued › Cash Flow › Change in Cash
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect · last filed 2022-05-04
- Intersect ENT, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2022-03-31 was -$13.82M, a 875.76% decline year-over-year.
- Intersect ENT, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2021-03-31 was $1.78M, a 86.84% decline year-over-year.
- Intersect ENT, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2020-03-31 was $13.54M.
- Intersect ENT, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2019-03-31 was -$871.00K.
- Intersect ENT, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2021 was $25.91M, a 149.89% increase from fiscal 2020.
- Intersect ENT, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2020 was $10.37M, a 7.32% decline from fiscal 2019.
- Intersect ENT, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2019 was $11.19M.
- Intersect ENT, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2018 was -$10.37M, a 203.96% decline from fiscal 2017.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 3 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 6 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 9 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 12 month |
|---|---|---|---|---|
| 2022-03-31 | -$13.82M 10-Q · filed 2022-05-04 | |||
| 2021-12-31 | $25.91M 10-K · filed 2022-03-08 | |||
| 2021-09-30 | $46.14M 10-Q · filed 2021-11-02 | |||
| 2021-06-30 | $8.78M 10-Q · filed 2021-08-06 | |||
| 2021-03-31 | $1.78M 10-Q · filed 2022-05-04 | |||
| 2020-12-31 | $10.37M 10-K · filed 2022-03-08 | |||
| 2020-09-30 | $36.24M 10-Q · filed 2021-11-02 | |||
| 2020-06-30 | $8.81M 10-Q · filed 2021-08-06 | |||
| 2020-03-31 | $13.54M 10-Q · filed 2021-05-10 | |||
| 2019-12-31 | $11.19M 10-K · filed 2022-03-08 | |||
| 2019-09-30 | $890.00K 10-Q · filed 2020-11-02 | |||
| 2019-06-30 | -$106.00K 10-Q · filed 2020-08-05 | |||
| 2019-03-31 | -$871.00K 10-Q · filed 2020-05-11 | |||
| 2018-12-31 | -$10.37M 10-K · filed 2021-03-09 | |||
| 2017-12-31 | $9.98M 10-K · filed 2020-02-27 |